KRAS ACTIVATING MUTATION

Clinical trials for KRAS ACTIVATING MUTATION explained in plain language.

Never miss a new study

Get alerted when new KRAS ACTIVATING MUTATION trials appear

Sign up with your email to follow new studies for KRAS ACTIVATING MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

Last-Hope cancer drug offered to desperate patients

Disease control AVAILABLE

This program provides access to an investigational drug called ulixertinib for patients with advanced cancers that have specific genetic changes (MAPK pathway mutations). It is for people who have run out of other treatment options. The drug aims to control the cancer's growth, e…

Matched conditions: KRAS ACTIVATING MUTATION

Sponsor: xCures • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

KRAS ACTIVATING MUTATION

Get alerted when new KRAS ACTIVATING MUTATION trials appear

Last-Hope cancer drug offered to desperate patients